Smith Rachel Ruckdeschel, Barile Lucio, Messina Elisa, Marbán Eduardo
Capricor Inc., Los Angeles, California, USA.
Heart Rhythm. 2008 May;5(5):749-57. doi: 10.1016/j.hrthm.2008.02.010. Epub 2008 Feb 15.
New approaches for cardiac repair have been enabled by the discovery that the heart contains its own reservoir of stem cells. These cells are positive for various stem/progenitor cell markers, are self-renewing, and exhibit multilineage differentiation potential. Recently we developed a method for ex vivo expansion of cardiac-derived stem cells from human myocardial biopsies with a view to subsequent autologous transplantation for myocardial regeneration. Here we review the state of the cardiac stem cell field and our own work on cardiosphere-derived stem cells from human hearts. The first of this two-part review outlines emerging preclinical data on the application of cardiac stem cells. Part 2 continues with a discussion of other stem cell sources with clinical potential, a summary of the critical issues surrounding stem cell therapy (with an emphasis on the crucial issue of how cell transplantation may influence arrhythmias), our perception of clinical stem cell trials to date, and the issues facing the clinical application of cardiac stem cells.
心脏中存在自身干细胞库这一发现,为心脏修复带来了新方法。这些细胞对多种干细胞/祖细胞标志物呈阳性反应,具有自我更新能力,并展现出多谱系分化潜能。最近,我们开发了一种从人类心肌活检组织中体外扩增心脏来源干细胞的方法,旨在随后进行自体移植以实现心肌再生。在此,我们综述心脏干细胞领域的现状以及我们自身关于源自人类心脏的心球样干细胞的研究工作。这篇两部分综述的第一部分概述了关于心脏干细胞应用的新出现的临床前数据。第二部分继续讨论其他具有临床潜力的干细胞来源,总结围绕干细胞治疗的关键问题(重点关注细胞移植如何影响心律失常这一关键问题),我们对迄今临床干细胞试验的看法,以及心脏干细胞临床应用所面临的问题。